FDA Accepts Supplemental NDA for Percodan by Endo Operations
The FDA has accepted a supplemental NDA for Percodan, which contains aspirin and oxycodone hydrochloride.
Asset / Drug
Drug and asset intelligence for Percodan with 4 indexed intelligence signals across regulatory, clinical, competitive, and market developments.
No catalysts indexed for this entity yet.
No related entities indexed yet.
Newsletter
Concise strategic intelligence on regulatory, clinical, competitive, and market developments — free to subscribe.
No paywall. No spam. Unsubscribe anytime.